Amanote Research
Register
Sign In
Treatment Patterns Among Patients Prescribed Pde-5 Inhibitor Monotherapy for Pulmonary Hypertension
Value in Health
- United Kingdom
doi 10.1016/j.jval.2016.03.159
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2016
Authors
J Yeaw
C Lickert
W Drake
AP De
RL Wade
Publisher
Elsevier BV
Related search
Case Report: A Patient With Pulmonary Arterial Hypertension Transitioning From a PDE-5 Inhibitor to Riociguat
BMC Pulmonary Medicine
Pulmonary
Respiratory Medicine
Pcv111 - Clinical Characteristics and Treatment Patterns Among Patients With Venous Thromboembolism Prescribed Anticoagulants in Germany
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
EXPRESS: Treatment Patterns, Healthcare Resource Utilization, and Healthcare Costs Among Patients With Pulmonary Arterial Hypertension in a Real-World US Database
Pulmonary Circulation
Pulmonary
Respiratory Medicine
Combining Bosentan and Sildenafil in Pulmonary Arterial Hypertension Patients Failing Monotherapy: Real-World Insights
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
STARTS-2: Long-Term Survival With Oral Sildenafil Monotherapy in Treatment-Naive Pediatric Pulmonary Arterial Hypertension
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Treatment of Pulmonary Hypertension
Italian Journal of Pediatrics
Child Health
Pediatrics
Perinatology
Phosphodiesterase Type 5 Inhibitors in the Treatment of Pulmonary Arterial Hypertension
Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
Assisting Pulmonary Hypertension Patients and Families With Treatment Decisions
Advances in Pulmonary Hypertension
Tyrosine Kinase Inhibitor–Induced Pulmonary Arterial Hypertension
Advances in Pulmonary Hypertension
